Clinical Trial Detail

NCT ID NCT01879085
Title Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hussein Tawbi
Indications

sarcoma

Therapies

Gemcitabine

Docetaxel

Pegfilgrastim

Vorinostat

Age Groups: adult

No variant requirements are available.